Loading Events

2026 U.S.-Japan Healthcare Connection Reverse Pitch Event

May 12 2026, 4:00 pm - 6:30 pm

Triple Ring Technologies

39655 Eureka Dr
Newark, CA 94560 United States

+ Google Map

*In-person program
Come hear pitches from leading Japan-focused strategic investors and pharmaceutical companies including AN Ventures, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Nippon Life, Ono Pharmaceuticals and Recor Medical. Our presenters will share their investment and partnering priorities with the audience, and tell you how to connect with them to discuss strategic partnering opportunities.

This is an amazing opportunity to get in front of leading US biotech, pharma and life science strategic partners and investors that are interested in startup life science firms. In addition, we will have a panel discussion featuring market-entry experts from the life sciences industry who will share their thoughts on the topic “Why do Therapeutics in Japan?

This Biopharma-focused event is our sixth Reverse Pitch event – following on the heels of our successful Medtech and Diagnostics Reverse Pitch event in November 2025. The event will be followed by a networking reception where you will have the opportunity to connect with the presenters and others with deep experience in the Japanese market.

Date: Tuesday, May 12th, 2026 from 4-6:30 PM PT

Venue: Triple Ring Technologies | 39655 Eureka Dr., Newark, CA 94560 United States
*Parking is available on-site

Agenda:

4:00-4:05 PM PT Opening Remarks | Loretta Hillberry, Triple Ring Technology
4:05-4:45 PM PT Pitches

  • AN VC | Ken Horne, Managing Partner
  • Astellas Venture Management | Satoshi Konagai, Investment Lead
  • Chugai Pharma USA | Seiichi Inamura, Director of Partnering
  • Daiichi Sankyo | Takahiro Nagayama, Head of Research Institute San Diego
4:45-5:00 PM PT Program: Why do Therapeutics in Japan?

  • Corporate Strategy and M&A Leader | Ray Fujii
  • AZCA, Inc. | Zak Murase, Partner
  • Moderator: McDermott Will & Schulte | Paul Gadiock, Partner (San Francisco Office)
5:00-5:15 PM PT Break
5:15-5:45 PM PT Pitches

  • Nippon Life Global Investors Americas, Inc | Hinako (Hayley) Nakagawa, Global Ventures & Partnerships Analyst
  • Ono Venture Investment, Inc (OVI) | Shunichiro Matsumoto, Ph.D., President & CEO
  • Recor Medical | Kenichiro Kubo, Director of Executive Projects
5:45-6:30 PM PT
Networking

Reverse Pitch Presenters

Ken Horne | Managing Partner, AN VC

Satoshi Konagai | Investment Lead, Astellas Venture Management

Seiichi Inamura | Director of Partnering, Chugai Pharma USA

Takahiro Nagayama | Head of Research Institute San Diego, Daiichi Sankyo

Hinako (Hayley) Nakagawa | Global Ventures & Partnerships Analyst at Nippon Life Global Investors Americas, Inc

Shunichiro Matsumoto, Ph.D. | President & CEO, Ono Venture Investment, Inc (OVI)

Kenichiro Kubo | Director of Executive Projects, Recor Medical

"Why do Therapeutics in Japan?" Speakers

Ray Fujii

Moderator: Paul Gadiock | Partner, McDermott Will & Schulte, San Francisco Office

Zak Murase | Partner, AZCA, Inc.